Facts of Ozempic (semaglutide)
OZEMPIC® (semaglutide) injection, for subcutaneous use
Initial U.S. Approval: 2017
Injection: 2 mg/1.5 mL (1.34 mg/mL) available in:
•Single-patient-use pen that delivers 0.25 mg or 0.5 mg per injection (3).
•Single-patient-use pen that delivers 1 mg per injection (3).
Company: Novo Nordisk Inc.
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Ozempic (semaglutide) ” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Ozempic (semaglutide) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Ozempic is?
Ozempic® (semaglutide) injection 0.5 mg or 1 mg is an injectable prescription medicine used:
- along with diet and exercise to improve blood sugar in adults with type 2 diabetes.
- to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes with known heart disease.
What semaglutide is?
Semaglutide (trade names Rybelsus, Ozempic) is a medication used for the treatment of type 2 diabetes. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.